Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH

NCT02893826 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped Based on DMC recommendation to discontinue EG-01-1962-03

Conditions

Subarachnoid Hemorrhage, Aneurysmal

Interventions

DRUG: EG-1962 (nimodipine microparticles)
DRUG: Enteral Nimodipine

Sponsor

Edge Therapeutics Inc